Earnings Feed
Start Free
Home/Filings/4/0000950170-24-100180
4//SEC Filing

Sinclair Andrew 4

Accession 0000950170-24-100180

CIK 0001720580other
View on SEC.govCompany Profile

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 4:08 PM ET

Size

24.8 KB

Accession

0000950170-24-100180

Insider Transaction Report

Form 4
Period: 2024-08-21
Adicet Bio, Inc.ACET
Sinclair Andrew
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-21−28,828→ 0 total
    Exercise: $2.14Exp: 2031-03-01→ Common Stock (28,828 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-21−8,172→ 0 total
    Exercise: $2.14Exp: 2031-04-29→ Common Stock (8,172 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-21−18,500→ 0 total
    Exercise: $2.14Exp: 2032-06-01→ Common Stock (18,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-08-21+28,828→ 28,828 total
    Exercise: $15.75Exp: 2031-03-01→ Common Stock (28,828 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-21−18,500→ 0 total
    Exercise: $2.14Exp: 2031-04-29→ Common Stock (18,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-08-21+8,172→ 8,172 total
    Exercise: $15.93Exp: 2031-04-29→ Common Stock (8,172 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-08-21+18,500→ 18,500 total
    Exercise: $15.93Exp: 2031-04-29→ Common Stock (18,500 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-08-21+18,500→ 18,500 total
    Exercise: $11.49Exp: 2032-06-01→ Common Stock (18,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-08-21−26,400→ 0 total
    Exercise: $2.14Exp: 2033-05-31→ Common Stock (26,400 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-08-21+26,400→ 26,400 total
    Exercise: $5.20Exp: 2033-05-31→ Common Stock (26,400 underlying)
Footnotes (2)
  • [F1]Effective August 21, 2024, the Issuer's Board of Directors approved a rescission of the August 2023 stock option repricing for certain non-employee directors of the Issuer. All of the affected stock options have been reverted to their original exercise price as established at the time of the grant. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
  • [F2]The shares subject to this option are fully vested and exercisable as of the date hereof.

Documents

1 file

Issuer

Adicet Bio, Inc.

CIK 0001720580

→
Entity typeother

Related Parties

1
  • filerCIK 0001762451

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:08 PM ET
Size
24.8 KB
View on SEC.gov